242 related articles for article (PubMed ID: 25644149)
1. Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.
Kikushige Y; Miyamoto T
Int J Hematol; 2015 Nov; 102(5):528-35. PubMed ID: 25644149
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.
Kikushige Y; Miyamoto T
Int J Hematol; 2014 Oct; 100(4):335-40. PubMed ID: 25100497
[TBL] [Abstract][Full Text] [Related]
3. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.
Kikushige Y; Ishikawa F; Miyamoto T; Shima T; Urata S; Yoshimoto G; Mori Y; Iino T; Yamauchi T; Eto T; Niiro H; Iwasaki H; Takenaka K; Akashi K
Cancer Cell; 2011 Aug; 20(2):246-59. PubMed ID: 21840488
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cells: cancer involvement and myeloid leukemia.
Li XL; Xue Y; Yang YJ; Zhang CX; Wang Y; Duan YY; Meng YN; Fu J
Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1829-36. PubMed ID: 26044227
[TBL] [Abstract][Full Text] [Related]
5. Hematological malignancies: disease pathophysiology of leukemic stem cells.
Ramdass B; Chowdhary A; Koka PS
J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
[TBL] [Abstract][Full Text] [Related]
6. Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity.
Chiang CL; Hu EY; Chang L; Labanowska J; Zapolnik K; Mo X; Shi J; Doong TJ; Lozanski A; Yan PS; Bundschuh R; Walker LA; Gallego-Perez D; Lu W; Long M; Kim S; Heerema NA; Lozanski G; Woyach JA; Byrd JC; Lee LJ; Muthusamy N
Cell Rep; 2022 Jul; 40(3):111115. PubMed ID: 35858552
[TBL] [Abstract][Full Text] [Related]
7. Wnt Signaling in Hematological Malignancies.
Grainger S; Traver D; Willert K
Prog Mol Biol Transl Sci; 2018 Jan; 153():321-341. PubMed ID: 29389522
[TBL] [Abstract][Full Text] [Related]
8. Tracing the roots of cancer evolution.
Jiang Y; Elemento O
Cancer Discov; 2014 Sep; 4(9):995-7. PubMed ID: 25185189
[TBL] [Abstract][Full Text] [Related]
9. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
[TBL] [Abstract][Full Text] [Related]
10. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
11. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia.
Fecteau JF; Kipps TJ
Front Biosci (Schol Ed); 2012 Jan; 4(1):61-73. PubMed ID: 22202043
[TBL] [Abstract][Full Text] [Related]
13. Acquired initiating mutations in early hematopoietic cells of CLL patients.
Damm F; Mylonas E; Cosson A; Yoshida K; Della Valle V; Mouly E; Diop M; Scourzic L; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Kikushige Y; Davi F; Lambert J; Gautheret D; Merle-Béral H; Sutton L; Dessen P; Solary E; Akashi K; Vainchenker W; Mercher T; Droin N; Ogawa S; Nguyen-Khac F; Bernard OA
Cancer Discov; 2014 Sep; 4(9):1088-101. PubMed ID: 24920063
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.
Chung SS; Kim E; Park JH; Chung YR; Lito P; Teruya-Feldstein J; Hu W; Beguelin W; Monette S; Duy C; Rampal R; Telis L; Patel M; Kim MK; Huberman K; Bouvier N; Berger MF; Melnick AM; Rosen N; Tallman MS; Park CY; Abdel-Wahab O
Sci Transl Med; 2014 May; 6(238):238ra71. PubMed ID: 24871132
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic transforming potential of activated ras in chimeric mice.
Hawley RG; Fong AZ; Ngan BY; Hawley TS
Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
[TBL] [Abstract][Full Text] [Related]
16. Gene mutations in chronic lymphocytic leukemia.
Amin NA; Malek SN
Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
[TBL] [Abstract][Full Text] [Related]
17. Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells.
Gezer D; Vukovic M; Soga T; Pollard PJ; Kranc KR
Stem Cells; 2014 Jun; 32(6):1390-7. PubMed ID: 24496882
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.
Yuan Y; Yu H; Boyer MJ; Song X; Cao S; Shen H; Cheng T
Cancer Res; 2006 Jan; 66(1):343-51. PubMed ID: 16397248
[TBL] [Abstract][Full Text] [Related]
19. Transformation from committed progenitor to leukemia stem cells.
Krivtsov AV; Feng Z; Armstrong SA
Ann N Y Acad Sci; 2009 Sep; 1176():144-9. PubMed ID: 19796242
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
